EP Patent

EP2125075A2 — Medical injector with compliance tracking and monitoring

Assigned to kaleo Inc · Expires 2009-12-02 · 16y expired

What this patent protects

A system (1002) includes a medicament delivery device (121O) and a container (1262) configured to receive at least a portion of the medicament delivery device. The medicament delivery device includes an actuator (1970) and a first electronic circuit system (1920) The actuator is …

USPTO Abstract

A system (1002) includes a medicament delivery device (121O) and a container (1262) configured to receive at least a portion of the medicament delivery device. The medicament delivery device includes an actuator (1970) and a first electronic circuit system (1920) The actuator is configured to initiate delivery of a medicament into a body when the actuator is moved from a first position to a second position. The first electronic circuit system is configured to output a first electronic signal when the actuator is moved from the first position to the second position. The container includes a second electronic circuit system configured to receive the first electronic signal. The second electronic circuit system is configured to output a second electronic signal associated with the first electronic signal.

Drugs covered by this patent

Patent Metadata

Patent number
EP2125075A2
Jurisdiction
EP
Classification
—
Expires
2009-12-02
Drug substance claim
No
Drug product claim
No
Assignee
kaleo Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.